A rare heterozygous TRAF6 variant is associated with hypohidrotic ectodermal dysplasia

British Journal of Dermatology

Volumn 166, Issue 6, 2012, Pages 1353-1356

  Wisniewski, S A ^a,b   Trzeciak, W H ^a  

^a Faculty of Public Health WSPiA   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ADOLESCENT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DNA SEQUENCE; DNA STRAND; DRY SKIN; EXON; FEMALE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOSITY; HUMAN; HYPERPIGMENTATION; HYPERTHERMIA; HYPODONTIA; HYPOHIDROTIC ECTODERMAL DYSPLASIA; MANDIBLE HYPOPLASIA; MAXILLA HYPOPLASIA; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SCANTY HAIR;

ADOLESCENT; ECTODERMAL DYSPLASIA; EXONS; FEMALE; FRAMESHIFT MUTATION; HETEROZYGOTE; HUMANS; SEQUENCE DELETION; TNF RECEPTOR-ASSOCIATED FACTOR 6;

EID: 84861639425     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10871.x     Document Type: Article

References (14)

1. Mikkola ML,. Molecular aspects of hypohidrotic ectodermal dysplasia. Am J Med Genet 2009; 149A: 2031-6.
2. Morlon A, Munnich A, Smahi A,. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd. Hum Mol Genet 2005; 14: 3751-7.
3. Naito A, Yoshida H, Nishioka E, et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci U S A 2002; 99: 8766-71.
4. Masotti C, Ornelas CC, Splendore-Gordonos A, et al. Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients. BMC Med Genet 2009; 10: 136.
5. Cluzeau C, Hadj-Rabia S, Jambou M, et al. Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. Hum Mutat 2011; 32: 70-2.
6. Yin Q, Lin SC, Lamothe B, et al. E2 interaction and dimerization in the crystal structure of TRAF6. Nat Struct Mol Biol 2009; 16: 658-66.
7. Chung JY, Lu M, Yin Q, et al. Molecular basis for the unique specificity of TRAF6. Adv Exp Med Biol 2007; 597: 122-30.
8. Kobayashi N, Kadono Y, Naito A, et al. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis. EMBO J 2001; 20: 1271-80.
9. Sinha S, Zachariah S, Quinones HI, et al. Role of TRAF3 and -6 in the activation of the NF-kappa B and JNK pathways by X-linked ectodermal dysplasia receptor. J Biol Chem 2002; 277: 44953-61.
10. Megas C, Hatzivassiliou EG, Yin Q, et al. Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-κB activation. Cell Signal 2011; 23: 772-7.
11. Lomaga MA, Yeh WC, Sarosi I, et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13: 1015-24.
12. Stachon P, Missiou A, Walter C, et al. Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans. PLoS ONE 2010; 5: e11589.
13. Chassaing N, Cluzeau C, Bal E, et al. Mutations in EDARADD account for a small proportion of hypohidrotic ectodermal dysplasia cases. Br J Dermatol 2010; 162: 1044-8.
14. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004; 101: 6062-7.